99mTc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model.

Article English OPEN
Miot-Noirault, Elisabeth; David, Emmanuelle; Vidal, Aurélien; Peyrode, Caroline; Besse, Sophie; Dauplat, Marie-Mélanie; Heymann, Marie-Françoise; Gouin, François; Chezal, Jean-Michel; Heymann, Dominique; Rédini, Françoise;
  • Publisher: BioMed Central
  • Journal: EJNMMI Research, volume 3, issue 1, pages 40-40 (issn: 2191-219X, eissn: 2191-219X)
  • Publisher copyright policies & self-archiving
  • Related identifiers: pmc: PMC3665493, doi: 10.1186/2191-219X-3-40
  • Subject: Proteoglycans | [ SDV.IB ] Life Sciences [q-bio]/Bioengineering | [ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/Imaging | Zoledronic acid | [SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging | Chondrosarcoma | Short Communication | 99mTc-NTP 15-5 radiotracer | [SDV.IB]Life Sciences [q-bio]/Bioengineering

International audience; BACKGROUND: Since proteoglycans (PGs) appear as key partners in chondrosarcoma biology, PG-targeted imaging using the radiotracer 99mTc-N-[triethylammonium]-3-propyl-[15]ane-N5 (99mTc-NTP 15-5) developed by our group was previously demonstrated t... View more
Share - Bookmark